India Excludes Chinese Companies From Its 5G Trials
NEW DELHI India has decided to proceed with its fifth-generation (5G) wireless network technology and spectrum trials and has invited equipment makers from various nations except China.
Experts say India is keeping Chinese 5G firms such as Huawei and ZTE out of its massive market because of the border dispute last year and because the exclusion will economically hurt Chinese entities.
The Department of Telecommunications of the Indian government on May 4 gave permission to its four telecom service providers (TSP) to conduct trials for the use and applications of 5G technology, according to a release by the Ministry of Communications.
Emily Schmall and Karan Deep Singh, The New York Times
Published: 08 May 2021 10:52 AM BdST
Updated: 08 May 2021 10:52 AM BdST FILE Adar Poonawalla, chief executive of the Serum Institute, in Pune, India, July 10, 2020. Poonawalla has acknowledged that the Serum Institute alone doesn’t have the capacity to vaccinate India anytime soon, much less shoulder the burden of inoculating the world’s poor, pledges he made earlier in the pandemic. (Atul Loke/The New York Times)
Adar Poonawalla made big promises. The 40-year-old chief of the world’s largest vaccine maker pledged to take a leading role in the global effort to inoculate the poor against COVID-19. His India-based empire signed deals worth hundreds of millions of dollars to make and export doses to suffering countries.
Synopsis Poonawalla defended his company and its ambitions. He had no choice but to hand over vaccines to the government, he said. He cited a lack of raw materials, which he has partially blamed on the United States. Making vaccines, he said, is a painstaking process that requires investment and major risks. He said he would return to India when he had finished his business in London.
AP
Poonawalla took the reins of the Serum Institute a decade ago from his father, Cyrus, a horse breeder turned vaccine billionaire.
Adar Poonawalla made big promises. The 40-year-old chief of the world’s largest vaccine maker pledged to take a leading role in the global effort to inoculate the poor against COVID-19. His India-based empire signed deals worth hundreds of millions of dollars to make and export doses to suffering countries.
New Delhi: Adar Poonawalla made big promises. The 40-year-old chief of the world’s largest vaccine maker pledged to take a leading role in the global effort to inoculate the poor against COVID-19. His India-based empire signed deals worth hundreds of millions of dollars to make and export doses to suffering countries.
Those promises have fallen apart. India, engulfed in a coronavirus second wave, is laying claim to his vaccines. Other countries and aid groups are now racing to find scarce doses elsewhere.
At home, politicians and the public have castigated Poonawalla and his company, the Serum Institute of India, for raising prices mid-pandemic. Serum has had production problems that have kept it from expanding output at a time when India needs every dose. He has come under criticism for departing to London amid the crisis, though he said it was only a quick trip. He told a British newspaper he had received threats from politicians and some of India’s “most powerful men,” d